We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
14 hedge funds and large institutions have $3.88M invested in Decoy Therapeutics in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
539% more capital invested
Capital invested by funds: $607K → $3.88M (+$3.27M)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
40% more funds holding
Funds holding: 10 → 14 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$1.35M |
| 2 |
Squarepoint
New York
|
+$87.9K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$87.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.6K |
| 5 |
XSC
X-Square Capital
Guaynabo,
Puerto Rico
|
+$58.6K |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
-$29.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$29.3K |
| 3 |
Two Sigma Investments
New York
|
-$10K |
